Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Investing

Stunalara Acceptances Reach 73.5%

by admin March 20, 2025
March 20, 2025
Stunalara Acceptances Reach 73.5%

Inca Minerals (ICG:AU) has announced Stunalara Acceptances Reach 73.5%

Download the PDF here.

This post appeared first on investingnews.com

previous post
Rock Chip Results Confirm Polymetallic Potential
next post
Highly successful first milling campaign completed

Related Posts

Benchmark: Surging Copper Prices Highlight Looming Global Supply...

March 11, 2026

5 Best-performing Canadian Pharma Stocks (Updated January 2026)

January 6, 2026

Results of General Meeting, Admission of Retail Offer...

March 25, 2025

Blackrock Silver Commences Eastern Expansion Drill Program Targeting...

July 21, 2025

David Morgan: Silver Squeeze 2.0 — Will Price...

March 31, 2025

Sarama Completes Tranche 2 Options Placement

February 11, 2025

GMV Minerals Inc. Announces Updated PEA Results at...

August 14, 2025

Grant of Equity Incentives

April 14, 2025

Lode Gold Strengthens Board of Spin Co Gold...

March 8, 2025

Editor’s Picks: Gold and Silver Prices Hit New...

January 31, 2026

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • Terms and Conditions
    • Privacy Policy

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wallstreetwizardry.com | All Rights Reserved